Riboflavin, or vitamin B2, plays an important role in the cell as biological precursor of FAD and FMN, two important flavin cofactors which are essential for the structure and function of flavoproteins. Riboflavin has been used in therapeutic approaches of various inborn errors of metabolism, notably in metabolic disorders resulting either from defects in proteins involved in riboflavin metabolism and transport or from defects in flavoenzymes. The scope of this review is to provide an updated perspective of clinical cases in which riboflavin was used as a potential therapeutic agent in disorders affecting mitochondrial energy metabolism. In particular, we discuss available mechanistic insights on the role of riboflavin as a pharmacological chaperone for the recovery of misfolded metabolic flavoenzymes.
http://ift.tt/2cdwtB5
http://ift.tt/2bYHgLF
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Survival after radiotherapy versus radical cystectomy for primary muscle‐invasive bladder cancer: A Swedish nationwide population‐based coho...
-
MRI and ultrasonographic imaging of a patient with carotidynia. : Authors: Kuhn J, Harzheim A, Horz R, Bewermeyer H Abstract A patient...
-
Basicranium malformation with anterior dislocation of right styloid process causing stylalgia.: Authors: Renzi G, Mastellone P, Le...
-
Publication date: Available online 12 March 2017 Source: Journal of Bodywork and Movement Therapies Author(s): Stephen Levin, Susan Lowell...
-
Publication date: Available online 5 May 2017 Source: Clinical Imaging Author(s): Toshinori Nishizawa, Soichiro Yoshida, Fumitaka Koga, Hi...
-
Publication date: June 2017 Source: Data in Brief, Volume 12 Author(s): Rachel L. Golda, Mark D. Golda, Tawnya D. Peterson, Joseph A. Need...
-
http://ift.tt/2kHqXYJ http://ift.tt/2kNc2vC
-
Abstract Little is known about specific modes of death in patients with heart failure with preserved ejection fraction (HFpEF). Herein, the...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου